Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease ; volume:16 ; number:1 ; day:16 ; month:9 ; year:2024 ; pages:1-12 ; date:12.2024
Alzheimer's research & therapy ; 16, Heft 1 (16.9.2024), 1-12, 12.2024
- Urheber
-
Wuestefeld, Anika
Pichet Binette, Alexa
van Westen, Danielle
Strandberg, Olof
Stomrud, Erik
Mattsson-Carlgren, Niklas
Janelidze, Shorena
Smith, Ruben
Palmqvist, Sebastian
Baumeister, Hannah
Berron, David
Yushkevich, Paul A.
Hansson, Oskar
Spotorno, Nicola
Wisse, Laura E.M
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-024-01571-z
- URN
-
urn:nbn:de:101:1-2411292104164.537300604263
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wuestefeld, Anika
- Pichet Binette, Alexa
- van Westen, Danielle
- Strandberg, Olof
- Stomrud, Erik
- Mattsson-Carlgren, Niklas
- Janelidze, Shorena
- Smith, Ruben
- Palmqvist, Sebastian
- Baumeister, Hannah
- Berron, David
- Yushkevich, Paul A.
- Hansson, Oskar
- Spotorno, Nicola
- Wisse, Laura E.M
- SpringerLink (Online service)
Ähnliche Objekte (12)
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Heterogeneity of factors associated with cognitive decline and cortical atrophy in early- versus late-onset Alzheimer’s disease
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Early and late-onset Alzheimer’s disease: What are the differences?
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease
A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Heterogeneity of factors associated with cognitive decline and cortical atrophy in early- versus late-onset Alzheimer’s disease
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Early and late-onset Alzheimer’s disease: What are the differences?
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease
A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Heterogeneity of factors associated with cognitive decline and cortical atrophy in early- versus late-onset Alzheimer’s disease
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Early and late-onset Alzheimer’s disease: What are the differences?
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease